Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small lymphocytic lymphoma ...
Jun 16, 2013 · Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small ...
Genome-wide association studies (GWAS) of chronic lymphocytic leukemia (CLL) have shown that common genetic variation contributes to the heritable risk of CLL.
Jan 28, 2021 · Prognostication in patients with chronic lymphocytic leukemia (CLL) is challenging due to heterogeneity in clinical course.
Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small lymphocytic lymphoma ...
Despite limited discovery stages (<1,125 cases), genome-wide association studies (GWAS) have successfully identified 13 loci associated with risk of chronic ...
have successfully identified 13 loci associated with risk of chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL). To identify additional CLL ...
Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small lymphocytic lymphoma ( ...
People also ask
What type of information does a genome-wide association study reveal?
Do GWAS identified risk variants for chronic lymphocytic leukemia influence overall patient survival and disease progression?
What kind of diseases are studied using genome-wide association studies?
What gene mutations occur in chronic lymphocytic leukemia?
Jun 16, 2024 · Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small ...
Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small lymphocytic lymphoma ( ...